Marantz Jing L.insider trades

In SEC Form 4 filings, Marantz Jing L. is listed as EVP, Chief Medical Officer of Intellia Therapeutics, Inc. (NTLA). Marantz Jing L. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 28.

Companies and roles

Company	Role	Transactions	Last filed
NTLAIntellia Therapeutics, Inc.	EVP, Chief Medical Officer	2	Oct 28

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-28

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NTLAIntellia Therapeutics, Inc.	Oct 26	Oct 28	A	199,822	$0.00	$0	199,822	No	Form 4
NTLAIntellia Therapeutics, Inc.	Oct 26	Oct 28	A · derivative	275,061	$11.26	$3,097,187	275,061	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.